Literature DB >> 10518621

Construction of a recombinant adenovirus for efficient delivery of the I-SceI yeast endonuclease to human cells and its application in the in vivo cleavage of chromosomes to expose new potential telomeres.

M Anglana1, S Bacchetti.   

Abstract

We have constructed a replication-defective adenovirus vector encoding the yeast I- Sce I endonuclease under the control of the murine cytomegalovirus immediate-early gene promoter (AdM Sce I) for efficient delivery of this enzyme to mammalian cells. We present evidence of AdM Sce I-mediated I- Sce I protein expression and cleavage activity in replication-permissive 293 cells, and of cleavage of chromosomes in vivo in both 293 cells and in non-permissive human cells. We have exploited this system for the generation of chromosomes capped by artificial telomeric sequences in cells with integrated plasmids containing telomeric DNA arrays adjacent to an I- Sce I recognition site. The properties of the AdM Sce I virus described here make it a useful tool for studying biological processes involving induction of DNA breaks, recombination and gene targeting in cells grown in culture and in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518621      PMCID: PMC148704          DOI: 10.1093/nar/27.21.4276

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  11 in total

1.  Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining.

Authors:  Sheema Fnu; Elizabeth A Williamson; Leyma P De Haro; Mark Brenneman; Justin Wray; Montaser Shaheen; Krishnan Radhakrishnan; Suk-Hee Lee; Jac A Nickoloff; Robert Hromas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 2.  Chromatin remodeling and repair of DNA double-strand breaks.

Authors:  Lai-Yee Wong; Judith Recht; Brehon C Laurent
Journal:  J Mol Histol       Date:  2006-08-08       Impact factor: 2.611

3.  Stimulation of homology-directed repair at I-SceI-induced DNA breaks during the permissive life cycle of human cytomegalovirus.

Authors:  A S Kulkarni; E A Fortunato
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

4.  Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors.

Authors:  Paola Neri; Li Ren; Kathy Gratton; Erin Stebner; Jordan Johnson; Alexander Klimowicz; Peter Duggan; Pierfrancesco Tassone; Adnan Mansoor; Douglas A Stewart; Sagar Lonial; Lawrence H Boise; Nizar J Bahlis
Journal:  Blood       Date:  2011-09-13       Impact factor: 22.113

5.  Nitric oxide-dependent downregulation of BRCA1 expression promotes genetic instability.

Authors:  Vasily A Yakovlev
Journal:  Cancer Res       Date:  2012-10-29       Impact factor: 12.701

6.  Meganuclease-mediated virus self-cleavage facilitates tumor-specific virus replication.

Authors:  Engin Gürlevik; Peter Schache; Anneliese Goez; Arnold Kloos; Norman Woller; Nina Armbrecht; Michael P Manns; Stefan Kubicka; Florian Kühnel
Journal:  Mol Ther       Date:  2013-06-11       Impact factor: 11.454

7.  DNA damage enhances integration of HIV-1 into macrophages by overcoming integrase inhibition.

Authors:  Takayoshi Koyama; Binlian Sun; Kenzo Tokunaga; Masashi Tatsumi; Yukihito Ishizaka
Journal:  Retrovirology       Date:  2013-02-21       Impact factor: 4.602

8.  A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin.

Authors:  David A Alagpulinsa; Srinivas Ayyadevara; Robert Joseph Shmookler Reis
Journal:  Front Oncol       Date:  2014-10-30       Impact factor: 6.244

9.  Human Cell Assays for Synthesis-Dependent Strand Annealing and Crossing over During Double-Strand Break Repair.

Authors:  Grzegorz Zapotoczny; Jeff Sekelsky
Journal:  G3 (Bethesda)       Date:  2017-04-03       Impact factor: 3.154

10.  Modulation of homology-directed repair in T98G glioblastoma cells due to interactions between wildtype p53, Rad51 and HCMV IE1-72.

Authors:  Amit S Kulkarni; Elizabeth A Fortunato
Journal:  Viruses       Date:  2014-02-26       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.